Oti tika poraka peka paihere

I roto i tenei tuhinga whakaaro tatou i tenei māuiuitanga rite pā pahara o te huha matau poraka manga paihere. Tenei ofatiraa wāhanga o ponana hiko i roto i te ngakau. Ko te nuinga o asymptomatic tenei mate, engari taunakitanga o te mate ngakau organic me whakaawe te putanga o te mate tuatahi. E hāngai ana te tātaritanga te i runga i nga hua o akoranga electrocardiographic. Ko oti tika poraka peka paihere i te kotahi me te hawhe ki katoa wha-whakatekau ōrau e rua o nga take, me ki tau, ake i anake enei whika. I roto i ngā momo katoa o blockades i roto i te auautanga runga tenei māuiuitanga te rua.

Etiology o tona takanga

Ko te take e taea te mahi i rite te kohakore ngakau, mate te AVC me te tuwhena rawa o anti-arrhythmia, ngakau pūkahukahu, stenosis o te piha mitral, takawhita pūkahukahu, vaolo ngakau tricuspid, whakapeka infarction myocardial, myocarditis, manawa, ngakau hypertensive, tāne i o electrolytes i te tinana, me te hypertrophy ventricular tika. Tino onge oti tika poraka manga paihere pāngia i roto i taitamariki pakeke hauora. I roto i ngā take pēnei i, e korero tatou e pā ana ki he noa.

Oti tika poraka peka paihere ko te take whakapōturinga tuku atu e rua pakohu me ngātere mōwaho ki runga. Tenei, i roto i te tahuri, arata'i ki te huringa uruhi i roto i te raupapa excitation o etahi o nga wahi o te ventricles tika rawa ana roro ranei.

pā oti poraka manga matau paihere: te tohu

I roto i te nuinga o te wā, e kore e tenei māuiuitanga meinga tetahi tohu kite, no te mea te manawataki me te auau o te ngakau e kore e pāngia.

Tātaritanga o tenei mate, rite whakahuatia i runga ake, e hāngai ana i runga i ngā raraunga i whiwhi e te tikanga o te rangahau electrocardiographic.

Tenei ko te rārangi o tohu e te hunga kitea i runga taua mea:

• nui haere QRS roanga matatini te paku, ki runga ki te iwa tekau ma tahi ranei haurau o te tuarua.
• I roto i te S niho tuatahi, me te v6 e arata'i paku whānui me te tika w1 uma QRS kāhakitanga matatini tohu rSr, rsR ranei.

Oti pā poraka manga tika paihere: maimoatanga

Ko te roanga me te pūmautanga o te māuiuitanga ngā maha e kore e rapua e tetahi maimoatanga. Otiia i roto i te āhuatanga i reira hāngai tona ahua ki te whakahōhā o mate ngakau, he maimoatanga wā o te faufaa nui mo te māori o kawenga cardiac. Ki te rua waewae pā kē, kaiwhakahaere rangitahi whakaaturia, ngā te whakanui ake i te roanga o Hv-wā i runga i 80-100 hākonamano. tūroro katoa pakeke ki abnormalities āriponga taua e ngohengohe ki te hohipera herea. I roto i te disorders whakapeka, me i te ngaro o te therapy contraindications tarukino taea te tono, i waho wareware te inconstancy me unreliability o taua tikanga ki te whakaawe i tēnei māuiuitanga. I roto i te take pai, ka taea e koe te tatau i runga i te pānga rangitahi.

E whakamahia ratou mo te maimoatanga o taua hua:

1. Anticholinergics, e whakaiti awe vagal, hei tauira 0.1% atropine kotahi ritamano pâmuhia me 0.2% platifillin rite kotahi ritamano rite subcutaneously, e pâmuhia, engari i roto i tenei take, ko te mea e tika ana ki te whakauru 5% te kūhuka i roto i rōrahi ki te 500 ml ranei.
2. Formulations whakapakari pānga o te pūnaha kawenga cardiac kaungāongo'i, hei tauira, 5% ephedrine kotahi ritamano intramuscularly, subcutaneously, e pâmuhia ranei, 0.2% norepinephrine, i roto i te rōrahi o te 1 ml, whakahaeretia i runga i te kūhuka 0.05% alupent hawhe ranei ki tetahi kupiki, whakahaere izadrin e rua intramuscularly me pâmuhia, 0.1% ranei i roto i te kotahi rōrahi ritamano.
3. Ka rite ki whakamahia hormones glucocorticosteroid, hei tauira, hydrocortisone, i te tere o runga ki te 200 mg ia ra.
4. Ki te whakaiti i te ihirangi o te pāhare pāporo he minaminatia ki te whakamahi i 1% o Lasix i tetahi rahinga ritamano.

Ko te tino pai waitohunga o tenei mate, engari, i homai te mōrea o whakahōhā ratou katoa o e pā ana mate cardiac, me kia tino tino ki tona maimoatanga.